ATC Group: B01AC06 Acetylsalicylic acid

Anatomical Therapeutic Chemical Classification System

Hierarchical position in ATC classification

Level
Code
Title
1
Blood and blood forming organs
2
Antithrombotic agents
3
Antithrombotic agents
4
Platelet aggregation inhibitors excl. heparin
5
B01AC06
Acetylsalicylic acid

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
1 {dose}

Active ingredients

Active Ingredient
Description

Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs.

Medicines in this ATC group

Drug
Countries

Lithuania Poland

Lithuania Poland

Hong Kong

Poland

Poland

Lithuania

Canada Ecuador

Ireland

Finland Germany Poland United Kingdom

Australia

Finland Spain

Hong Kong Singapore

Ireland South Africa

Australia

Lithuania Poland

Australia Hong Kong New Zealand Singapore

Australia Hong Kong New Zealand

United Kingdom

Ecuador

Singapore

Germany

Lithuania

Austria Lithuania

Estonia Germany

Estonia Lithuania

France Tunisia

United Kingdom

Cyprus Ireland United Kingdom

Ireland

Lithuania

Canada

Australia

Austria Estonia Lithuania

Related product monographs

Title
Type
Country
Structured Product Monograph (SPM)
CA
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
IE
Summary of Product Characteristics (SPC)
UK